Neonatal polycythemia (patient information): Difference between revisions

Jump to navigation Jump to search
m (Robot: Changing Category:Disease state to Category:Disease)
m (Robot: Automated text replacement (-mgibson@perfuse.org +charlesmichaelgibson@gmail.com, -kfeeney@perfuse.org +kfeeney@elon.edu))
 
Line 3: Line 3:
{{Neonatal polycythemia (patient information)}}
{{Neonatal polycythemia (patient information)}}


'''Editor-in-Chief:''' [[C. Michael Gibson]], M.S.,M.D. [mailto:mgibson@perfuse.org] Phone:617-632-7753; '''Associate Editor(s)-In-Chief:''' [[Lakshmi Gopalakrishnan]], M.B.B.S.
'''Editor-in-Chief:''' [[C. Michael Gibson]], M.S.,M.D. [mailto:charlesmichaelgibson@gmail.com] Phone:617-632-7753; '''Associate Editor(s)-In-Chief:''' [[Lakshmi Gopalakrishnan]], M.B.B.S.


'''''Synonyms and Keywords:''''' Hyperviscosity - newborn
'''''Synonyms and Keywords:''''' Hyperviscosity - newborn

Latest revision as of 19:31, 1 November 2012

For the WikiDoc page for this topic, click here

Neonatal polycythemia

Overview

What are the symptoms?

What are the causes?

Diagnosis

Treatment options

Where to find medical care for Neonatal polycythemia?

What to expect (Outlook/Prognosis)?

Possible complications

Neonatal polycythemia On the Web

Ongoing Trials at Clinical Trials.gov

Images of Neonatal polycythemia

Videos on Neonatal polycythemia

FDA on Neonatal polycythemia

CDC on Neonatal polycythemia

Neonatal polycythemia in the news

Blogs on Neonatal polycythemia

Directions to Hospitals Treating Neonatal polycythemia

Risk calculators and risk factors for Neonatal polycythemia

Editor-in-Chief: C. Michael Gibson, M.S.,M.D. [1] Phone:617-632-7753; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S.

Synonyms and Keywords: Hyperviscosity - newborn

Overview

Hyperviscosity of the newborn is the slowing and blockage of blood flow that results when there are too many red blood cells in an infant's blood.

What are the symptoms of Neonatal polycythemia?

Symptoms may include:

  • Extreme sleepiness
  • Feeding problems
  • Seizures
  • Very ruddy (red) skin color

What causes Neonatal polycythemia?

  • Hyperviscosity can occur when the percentage of red blood cells (RBCs) in the infant's blood,, called the hematocrit, is greater than 65%. This may result from various conditions that develop before birth, such as:
  • The extra RBCs can block the flow of blood in the smallest blood vessels. This may lead to tissue death from lack of oxygen. This blocked blood flow can affect all organs, including the kidneys, lungs, and brain.

Diagnosis

  • If the baby has symptoms of hyperviscosity, a blood test to count the number of red blood cells will be done. This test is called a hematocrit.
  • Other tests may include:
  • Blood gases to check oxygen level in the blood
  • Blood sugar (glucose) to check for low blood sugar
  • Blood urea nitrogen (BUN), a substance that forms when protein breaks down
  • Creatinine, a substance produced by muscles that can build up in the blood if the kidneys aren't working properly
  • Urinalysis

Treatment options

  • The baby will be monitored for complications of hyperviscosity.
  • If needed, an exchange transfusion will be done to lower the amount of red blood cells that are moving through the baby's blood vessels.
  • Other treatment may include increasing body fluids.

Where to find medical care for Neonatal polycythemia?

Directions to Hospitals Treating Neonatal polycythemia

What to expect (Outlook/Prognosis)?

  • The outlook is good for infants with mild hyperviscosity and those who receive treatment for severe hyperviscosity.
  • Some children may have mild changes in neurological development. Parents who believe their child may show any signs of developmental delay should contact their health care provider.

Possible complications

Complications may include:

Source

http://www.nlm.nih.gov/medlineplus/ency/article/000536.htm

Template:WH Template:WS